|
Market Closed –
|
5-day change | 1st Jan Change | ||
|
5.280 USD |
+24.24% | +102.30% | +254.36% | |
Published on 05/23/2025 at 20:06
This article is reserved for members Unlock the article: REGISTER NOW!
© Reuters – 2025
|
Biosig Technologies Announced Streamex To Become Wholly Owned Subsidiary Of Biosig |
08:06pm |
RE |
|
BioSig Technologies Regains Compliance With Nasdaq’s Minimum Price Requirement |
May. 15 |
MT |
|
BioSig Plans To Merge With Streamex Exchange Creating A Publicly Listed Asset Tokenization Company |
May. 05 |
RE |
|
BioSig Technologies, Inc. Announces CEO Changes |
May. 05 |
CI |
|
BioSig Technologies, Inc. Announces Board Changes |
May. 05 |
CI |
|
BioSig Technologies, Inc. signed a letter of intent to acquire Streamex Exchange Corporation. |
May. 04 |
CI |
|
BioSig Technologies Receives Nasdaq Notice For Minimum Bid Price Non-Compliance – SEC Filing |
Apr. 15 |
RE |
|
BioSig Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 |
Apr. 15 |
CI |
|
BioSig Technologies, Inc. Auditor Raises ‘Going Concern’ Doubt |
Apr. 14 |
CI |
|
BioSig Technologies Confirms Full Compliance With Nasdaq Requirements For Continued Listing On The Nasdaq Capital Market |
Mar. 26 |
RE |
|
BioSig Technologies, Inc. announced that it has received $0.818998 million in funding |
Mar. 25 |
CI |
|
Biosig Technologies Inc – On March 24, Regains Full Compliance For Nasdaq Listing |
Mar. 25 |
RE |
|
BioSig Technologies, Inc. announced that it expects to receive $0.818998 million in funding |
Mar. 04 |
CI |
|
BioSig Technologies, Inc. announced that it expects to receive $5 million in funding from The Lind Partners, LLC |
Feb. 27 |
CI |
|
BioSig Technologies, Inc. cancelled the acquisition of Assets of Neuro-Kinesis Inc. from Neuro-Kinesis Inc. |
Feb. 02 |
CI |
|
BioSig Technologies, Inc.(NasdaqCM:BSGM) added to S&P TMI Index |
Dec. 22 |
CI |
|
BioSig Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 |
Nov. 14 |
CI |
|
BioSig Technologies Regains Compliance With Nasdaq’s Minimum Price Requirement |
Nov. 13 |
MT |
|
BioSig Technologies, Inc.(NasdaqCM:BSGM) added to NASDAQ Composite Index |
24-10-23 |
CI |
|
BioSig Technologies, Inc. Appoints Mr. Anthony Amato as Chairman |
24-09-13 |
CI |
|
BioSig Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 |
24-08-14 |
CI |
|
BioSig Technologies, Inc. signed a letter of intent to acquire Assets of Neuro-Kinesis Inc. from Neuro-Kinesis Inc. |
24-07-30 |
CI |
|
BioSig Technologies, Inc.(NasdaqCM:BSGM) dropped from S&P TMI Index |
24-06-13 |
CI |
|
Sector Update: Health Care Stocks Softer Late Afternoon |
24-06-11 |
MT |
|
Top Midday Decliners |
24-06-11 |
MT |
BSGM: Dynamic Chart
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.
More about the company
Buy
Average target price
2.500USD
Spread / Average Target
-52.65%
Consensus
Quarterly revenue – Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
